62 completed, 49 unknown, 37 recruiting, 4 not yet recruiting. 68 Not applicable, 43 Phase 2, 15 Phase 4, 12 Phase 1, 9 Phase 3.
Follow Treatment: new trials by email Literature Review of Treatment trials Research Report on Treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Mandibular Overjet in Children With Maxillary Retrognathism Interceptive treatment - Maxillary Retrognathism, Children | Not applicable | Not yet recruiting | Malmö University | 180 | 2026-12-01 | 2026-10-22 |
| A Closed Surgical Technique vs Modified Papilla Preservation Technique Access Flap, Close Surgical Technique - Intrabony Periodontal Defect, Treatment | Not applicable | Recruiting | Aristotle University Of Thessaloniki | 40 | 2026-10-01 | 2026-11-05 |
| Effect of Melatonin Administration on Systemic Lupus Erythematosus Patients Melatonin - Therapy, Treatment | Phase 2 / Phase 3 | Not yet recruiting | Ain Shams University | 64 | 2026-07-21 | 2026-07-23 |
| Prevention of Relapse Through Cognitive Cycling in Patients With Alcohol Use Disorder Following Alcohol Withdrawal cognitive cycling - Cognitive Cycling, Alcohol Use Disorder (AUD) | Not applicable | Not yet recruiting | Centre Hospitalier Esquirol | 128 | 2026-07-08 | 2026-07-10 |
| Treatment Response in Patients With Medication-Overuse Headache Treatment outcome - Medication-overuse Headache, Treatment | Completed | Sultan 1. Murat State Hospital | 70 | 2026-03-17 | 2026-09-09 | |
| Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) Rituximab, Daratumumab - Immune Thrombocytopenia, Treatment | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 122 | 2026-03-01 | 2026-01-23 |
| Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) Rituximab combined with Daratumumab（Anti-CD38 Monoclonal Antibody） - Immune Thrombocytopenia, Treatment | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 20 | 2026-03-01 | 2026-01-23 |
| Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) Daratumumab（Anti-CD38 Monoclonal Antibody）, Rituximab - Immune Thrombocytopenia, Treatment | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 160 | 2026-01-28 | 2026-02-11 |
| Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) Rituximab, Daratumumab - Immune Thrombocytopenia, Treatment | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 160 | 2026-01-20 | 2026-02-11 |
| Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML Ivosidenib, Venetoclax, Azacitidine - AML, IDH1 Mutation | Phase 1 / Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 23 | 2025-10-17 | 2026-05-13 |
| Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema Micropulse Laser - Micropulse Laser, Treatment | Recruiting | The General Authority for Teaching Hospitals and Institutes | 50 | 2025-10-15 | 2025-12-22 | |
| Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection Potassium-Competitive Acid Blocker, Proton Pump Inhibitor - Potassium-Competitive Acid Blocker, Proton Pump Inhibitor | Not applicable | Recruiting | Tanta University | 320 | 2025-09-11 | 2025-09-12 |
| Multidimensional Sleep Health Intervention to Optimize Concussion Recovery Sleep Intervention - Concussion (Diagnosis), Concussion, Mild Traumatic Brain Injury | Not applicable | Recruiting | University of Colorado, Denver | 54 | 2025-09-10 | 2026-06-18 |
| Facilitators and Barriers to Eptinezumab Administration in Thailand Eptinezumab, Sham (No Treatment) - Migraine, Treatment | Completed | Chulalongkorn University | 30 | 2025-08-25 | 2026-04-08 | |
| Relationship Between Central Sensitization Levels and Treatment Outcomes in Frozen Shoulder Treatment Treatment outcome - Frozen Shoulder, Central Sensitisation | Completed | Sultan 1. Murat State Hospital | 87 | 2025-08-09 | 2025-12-31 | |
| Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP) Daratumumab Injection - Immune Thrombocytopenia, Treatment | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 30 | 2025-08-01 | 2025-07-14 |
| An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia CM336 Injection - Immune Thrombocytopenia (ITP), Treatment | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 20 | 2025-03-03 | 2025-03-13 |
| Evaluating the Effectiveness of an Adapted-Dialectical Behavior Therapy (A-DBT) Adapted Dialectical Behavioral Therapy (A-DBT) - Treatment | Not applicable | Completed | International Islamic University, Islamabad | 16 | 2025-03-01 | 2026-10-20 |
| A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia nicotinamide adenine dinucleotid/nicotinamide mononucleotide - Immune Thrombocytopenia, Treatment | Phase 1 / Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 20 | 2025-01-15 | 2025-08-05 |
| Evaluation of the Effectiveness of Arthrocentesis Using Catheter in the Treatment of Temporamandibular Joint Disorders Procedure: TMJ Arthrocentesis - TMJ Disc Disorder, Treatment | Not applicable | Completed | Eskisehir Osmangazi University | 30 | 2025-01-13 | 2026-10-16 |
Showing 20 of 161. Sign in to see all of them.
Purpura, Thrombocytopenic, Idiopathic (15) · Disease (7) · Motor Activity (6) · Pain (5) · COVID-19 (4) · Fractures, Bone (4) · Depression (3) · Intracranial Aneurysm (3) · Substance-Related Disorders (3) · Adenocarcinoma of Lung (2) · Alcoholism (2) · Anxiety Disorders (2) · Brain Concussion (2) · Breast Neoplasms (2) · Cognitive Dysfunction (2)
Pathological Conditions, Signs and Symptoms (53) · Pathologic Processes (37) · Signs and Symptoms (33) · Immune System Diseases (25) · Autoimmune Diseases (22) · Hemic and Lymphatic Diseases (18) · Nervous System Diseases (17) · Blood Platelet Disorders (16) · Cytopenia (16) · Hematologic Diseases (16) · Skin Manifestations (16) · Behavior (15) · Blood Coagulation Disorders (15) · Hemorrhage (15) · Hemorrhagic Disorders (15)
Rituximab (5) · daratumumab (4) · Exercise (3) · Methods (3) · Therapeutics (3) · Cisplatin (2) · Control Groups (2) · Cyclophosphamide (2) · Dexamethasone (2) · Drug Therapy (2) · Injections (2) · Ribavirin (2) · Sugars (2) · Treatment Outcome (2) · Triamcinolone Acetonide (2)
Institute of Hematology & Blood Diseases Hospital, China (18) · Changhai Hospital (5) · Colaris, Joost, M.D. (4) · Tanta University (4) · Chulalongkorn University (3) · Ain Shams University (2) · Asociación para Evitar la Ceguera en México (2) · Centers for Disease Control and Prevention (2) · Eskisehir Osmangazi University (2) · Hacettepe University (2) · Norwegian Institute of Public Health (2) · Peking University Third Hospital (2) · Shanghai Zhongshan Hospital (2) · Sultan 1. Murat State Hospital (2) · The First Affiliated Hospital with Nanjing Medical University (2)
China (55) · United States (17) · Egypt (10) · Turkey (Türkiye) (8) · Brazil (6) · France (5) · Pakistan (5) · Netherlands (4) · Sweden (4) · Denmark (3) · Germany (3) · Italy (3) · Mexico (3) · South Korea (3) · Spain (3)
Lei Zhang, MD (12) · David R Howell, PhD (2) · Lindi Jiang, PhD (2) · Meifang Han, Doctor (2) · Xian Dong Zeng, M.D. (2) · Zhen Jun Wang, M.D. (2) · Akarin Hiransuthikul, MD, MSc (1) · Anila Sadaf, PhD (1) · Anne Reneflot, PhD (1) · Bao Ming Zhao, M.D. (1) · Barbara Soltes, MD (1)
PMID 17143848, PMID 18720541, PMID 21054824, PMID 21990811, PMID 22700728, PMID 22837306, PMID 23041227, PMID 23091316, PMID 23536769, PMID 26922877, PMID 27449221, PMID 28486314, PMID 28618972, PMID 29103962, PMID 29244893, PMID 30772348, PMID 31763689, PMID 31973779, PMID 32297874, PMID 32301973, PMID 32557558, PMID 32736597, PMID 33164825, PMID 33181549, PMID 33583057, PMID 33591032, PMID 33708786, PMID 34134874, PMID 34356652, PMID 34648934, PMID 34978855, PMID 35142858, PMID 35412950, PMID 35533704, PMID 35623240, PMID 35869820, PMID 36038164, PMID 36088618, PMID 36095315, PMID 36103365, PMID 36180115, PMID 36507781, PMID 36999825, PMID 37489818, PMID 37540159, PMID 37572581, PMID 37776953, PMID 37783805, PMID 37927428, PMID 37955951
2018 (1), R01CA284649 (1), R01HD108133 (1), R01MH064821 (1), R34AA026246 (1), U01AI148055 (1)